CSIMarket
 


Ibio inc   (IBIO)
Other Ticker:  
 

Ibio Inc 's Leverage Ratio

IBIO's quarterly Leverage Ratio and Total Liabilities, Equity growth


In Spite of the repayements of liabilities of -5.25%, in I Quarter 2023 ,Leverage Ratio deteriorated to 1.85, below the Ibio Inc 's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the first quarter 2023, 354 other companies have achieved lower Leverage Ratio than Ibio Inc in the I Quarter 2023. While Leverage Ratio total ranking has improved so far in the first quarter 2023 to 2529, from total ranking in the forth quarter 2023 at 2547 .

Explain Leverage Ratio?
Who are IBIO Customers?
What are IBIO´s Total Liabilities?


IBIO Leverage Ratio (Sep 30 2023)
I. Quarter
(Jun 30 2023)
IV. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
II. Quarter
(Sep 30 2022)
I. Quarter
Y / Y Equity Change -72.69 % -75.77 % -80.81 % -81.28 % -55.46 %
Y / Y Total Liabilities Change -32.4 % -28.1 % -24.69 % -23.66 % -5.7 %
Leverage Ratio MRQ 1.85 1.68 1.55 1.75 0.75
IBIO's Total Ranking # 2529 # 2547 # 2912 # 612 # 1496
Seq. Equity Change -14.12 % -11.55 % -7.62 % -61.08 % -23.81 %
Seq. Total Liabilities Change -5.25 % -4.34 % -18.13 % -8.89 % 0.77 %



Leverage Ratio first quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 355
Healthcare Sector # 723
Overall Market # 2529


Leverage Ratio Statistics
High Average Low
15.43 2.03 0.06
(Dec 31 2011)   (Jun 30 2014)




Financial Statements
Ibio Inc 's Equity $ 13 Millions Visit IBIO's Balance sheet
Ibio Inc 's Total Liabilities $ 24 Millions Visit IBIO's Balance sheet
Source of IBIO's Sales Visit IBIO's Sales by Geography


Cumulative Ibio Inc 's Leverage Ratio

IBIO's Leverage Ratio for the trailling 12 Months

IBIO Leverage Ratio

(Sep 30 2023)
I. Quarter
(Jun 30 2023)
IV. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
II. Quarter
(Sep 30 2022)
I. Quarter
Y / Y Equity TTM Growth -72.69 % -75.77 % -80.81 % -81.28 % -55.46 %
Y / Y Total Liabilities TTM Growth -32.4 % -28.1 % -24.69 % -23.66 % -5.7 %
Leverage Ratio TTM 1.7 1.22 0.89 0.64 0.5
Total Ranking TTM # 2479 # 8 # 2111 # 78 # 962
Seq. Equity TTM Growth -14.12 % -11.55 % -7.62 % -61.08 % -23.81 %
Seq. Total Liabilities TTM Growth -5.25 % -4.34 % -18.13 % -8.89 % 0.77 %


On the trailing twelve months basis Despite of the repayements of liabilities of -5.25% in the trailing twelve months ending in I Quarter 2023, Leverage Ratio improved to 1.7, below Ibio Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 345, during the past 12 months, other companies have achieved lower Leverage Ratio than Ibio Inc . While Leverage Ratio total ranking has deteriorated during the twelve months ending in the I Quarter 2023, compared to the prior period, from 8 to 2479.

Explain Leverage Ratio?
Who are IBIO Customers?
What are IBIO´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 346
Healthcare Sector # 708
Within the Market # 2479


trailing twelve months Leverage Ratio Statistics
High Average Low
35.51 3.36 0.37
(Mar 31 2020)   (Sep 30 2021)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity
Clearmind Medicine Inc   5.05 $ 4.970  Millions$ 0.983  Millions
Innovation Pharmaceuticals Inc   4.74 $ 5.505  Millions$ 1.162  Millions
Amicus Therapeutics inc   4.73 $ 630.847  Millions$ 133.237  Millions
Unicycive Therapeutics Inc   4.72 $ 16.008  Millions$ 3.390  Millions
Teva Pharmaceutical Industries Limited  4.68 $ 35,158.000  Millions$ 7,512.000  Millions
Petros Pharmaceuticals inc   4.61 $ 31.982  Millions$ 6.933  Millions
Intercept Pharmaceuticals inc   4.47 $ 321.317  Millions$ 71.845  Millions
Blueprint Medicines Corporation  4.46 $ 902.688  Millions$ 202.611  Millions
Kala Bio inc   4.45 $ 49.897  Millions$ 11.223  Millions
Puma Biotechnology Inc   4.26 $ 164.863  Millions$ 38.742  Millions
Celularity Inc   4.20 $ 126.945  Millions$ 30.247  Millions
Mustang Bio inc   4.13 $ 16.558  Millions$ 4.009  Millions
Mersana Therapeutics Inc   4.04 $ 210.709  Millions$ 52.195  Millions
Vbi Vaccines Inc  3.88 $ 77.194  Millions$ 19.886  Millions
Aytu Biopharma Inc   3.13 $ 100.721  Millions$ 32.167  Millions
Sarepta Therapeutics Inc   3.04 $ 2,322.856  Millions$ 764.357  Millions
Eli Lilly And Company  2.94 $ 33,266.700  Millions$ 11,307.400  Millions
Harrow Inc   2.79 $ 210.308  Millions$ 75.402  Millions
Kineta Inc   2.77 $ 7.991  Millions$ 2.889  Millions
Marinus Pharmaceuticals Inc   2.65 $ 144.368  Millions$ 54.537  Millions
Journey Medical Corporation  2.62 $ 45.447  Millions$ 17.374  Millions
Durect Corp  2.55 $ 36.752  Millions$ 14.406  Millions
Apellis Pharmaceuticals Inc   2.52 $ 585.945  Millions$ 232.271  Millions
Proqr Therapeutics N v   2.33 $ 108.072  Millions$ 46.357  Millions
Gossamer Bio Inc   2.33 $ 243.308  Millions$ 104.617  Millions
Phibro Animal Health Corporation  2.27 $ 620.465  Millions$ 273.069  Millions
Uniqure N v   2.21 $ 594.878  Millions$ 268.784  Millions
Biovie Inc   2.15 $ 16.212  Millions$ 7.548  Millions
Bristol myers Squibb Company  2.14 $ 62,265.000  Millions$ 29,062.000  Millions
G1 Therapeutics Inc   2.09 $ 90.075  Millions$ 43.022  Millions

Date modified: 2023-12-13T10:37:32+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com